Dr. Jalkut is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3821 Ed Dr
Raleigh, NC 27612Phone+1 919-782-1255Fax+1 919-782-6550
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1998 - 2004
Stanford University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - Present
NC State Medical License 2004 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent Start of enrollment: 2021 Jun 24
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve Start of enrollment: 2021 Apr 22
Roles: Contact
Publications & Presentations
PubMed
- 35 citationsIL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.Karim Chamie, Sam S Chang, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal
NEJM Evidence. 2023-01-01 - 25 citationsEvaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.Robert L. Waterhouse, Leander Van Neste, Kelvin A. Moses, Carlton Barnswell, Jonathan L. Silberstein
Urology. 2019-06-01 - 21 citationsRole of prostate stem cell antigen in prostate cancer research.Mark Jalkut, Robert E. Reiter
Current Opinion in Urology. 2002-09-01
Press Mentions
- Solace Therapeutics Announces That Associate Urologists of North Carolina Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)November 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
